TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $749,000 | +72.2% | 9,959 | +9.2% | 0.00% | – |
| Q4 2021 | $435,000 | -37.7% | 9,121 | -13.2% | 0.00% | – |
| Q3 2021 | $698,000 | -0.3% | 10,513 | +17.2% | 0.00% | – |
| Q2 2021 | $700,000 | -20.0% | 8,968 | -3.1% | 0.00% | – |
| Q1 2021 | $875,000 | -68.6% | 9,255 | -59.5% | 0.00% | -100.0% |
| Q4 2020 | $2,788,000 | +157.7% | 22,880 | +84.7% | 0.00% | 0.0% |
| Q3 2020 | $1,082,000 | +225.9% | 12,389 | +141.6% | 0.00% | – |
| Q2 2020 | $332,000 | -20.2% | 5,127 | -23.2% | 0.00% | -100.0% |
| Q4 2019 | $416,000 | – | 6,674 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |